Home / Tag Archives: Type 1 diabetes treatment

Tag Archives: Type 1 diabetes treatment

The First Disease-Modifying Treatment After a Type 1 Diabetes Diagnosis: Why Teplizumab Is Changing the Conversation

Pediatric endocrinologist discussing teplizumab treatment options with a family following a new type 1 diabetes diagnosis.

For decades, treatment after a type 1 diabetes diagnosis focused almost entirely on insulin replacement and blood glucose management. While advances in technology have improved care, clinicians have had few ways to address the autoimmune process driving beta-cell loss. That is beginning to change. With the FDA’s expansion of teplizumab-mzwv …

Read More »

The Rise of “Double Diabetes”: Why More Adults With Type 1 Diabetes Are Developing Insulin Resistance

Adult with type 1 diabetes checking blood sugar levels alongside obesity and insulin resistance health concepts

More adults living with type 1 diabetes are now developing obesity, insulin resistance, hypertension, and metabolic complications once linked mainly to type 2 diabetes. This growing overlap, often called double diabetes, is becoming a major concern for clinicians and patients alike. While insulin therapy remains essential for type 1 diabetes …

Read More »

GLP-1 Use in Type 1 Diabetes: Where Adjunct Therapy May—and May Not—Make Sense

Medical setup showing insulin vial, GLP-1 injection pen, glucose meter, and pancreas model representing adjunct therapy in type 1 diabetes

GLP-1 receptor agonists as adjunct therapy in type 1 diabetes are gaining attention as clinicians look for new ways to improve glycemic control. But is this approach a promising tool or a risky shortcut? As emerging evidence builds, providers must balance potential benefits with safety concerns and patient-specific factors. Table …

Read More »

Pharmacoeconomics of Diabetes Care: A Healthcare Provider’s Perspective

Pharmacoeconomics is the study of the economic aspects of pharmaceutical products and services. It is used to assess the cost-effectiveness of pharmaceuticals and to inform decisions about drug utilization and reimbursement. Pharmacoeconomics of diabetes care is an important topic for healthcare providers, as it can help them to understand the …

Read More »

Assessing Type 1 Diabetes Risk: A Clinical View

Type 1 diabetes (T1D) is a chronic, autoimmune disorder in which the body’s own immune system attacks and destroys the insulin-producing cells of the pancreas. As a result, the body is unable to produce enough insulin to regulate blood sugar levels. Although the exact cause of T1D is unknown, research …

Read More »